EV Biologics, Inc. (YECO)

OTCMKTS · Delayed Price · Currency is USD
0.0822
-0.0063 (-7.12%)
At close: Feb 20, 2026
-6.59%
Market Cap 840.53K
Revenue (ttm) 9.47M
Net Income (ttm) -551.58K
Shares Out 10.23M
EPS (ttm) -0.23
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 5,000
Average Volume 2,630
Open 0.0822
Previous Close 0.0885
Day's Range 0.0822 - 0.0822
52-Week Range 0.0808 - 0.1056
Beta 0.64
RSI 43.59
Earnings Date n/a

About EV Biologics

EV Biologics, Inc., a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic and biopharmaceutical spaces. The company was formerly known as Yulong Eco-Materials Limited and changed its name to EV Biologics... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2011
Employees 284
Stock Exchange OTCMKTS
Ticker Symbol YECO
Full Company Profile

Financial Performance

In 2017, EV Biologics's revenue was $9.47 million, a decrease of -0.34% compared to the previous year's $9.51 million. Losses were -$551,581, -92.58% less than in 2017.

Financial Statements

News

There is no news available yet.